Back
Puma Biotechnology 10K Form
Sell
45
PBYI
Puma Biotechnology
Last Price:
4.88
Seasonality Move:
29.48%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PBYI News And Ratings
See the #1 stock for the next 7 days that we like better than PBYI
PBYI Financial Statistics
Sales & Book Value
Annual Sales: | $235.64M |
---|---|
Cash Flow: | $10.41M |
Price / Cash Flow: | 16.08 |
Annual Sales: | $1.12 |
Price / Book: | 4.38 |
Profitability
EPS (TTM): | 0.45000 |
---|---|
Net Income (TTM): | $21.59M |
Gross Margin: | $172.96M |
Return on Equity: | 63.49% |
Return on Assets: | 10.25% |
Puma Biotechnology Earnings Forecast
Key Puma Biotechnology Financial Ratios
- The Gross Profit Margin over the past 16 years for PBYI is 73.40%.
- The Selling, General & Administrative Expenses for PBYI have been equal to 37.53% of Gross Profit Margin.
- The Research & Development expenses have been 21.38% of Revenue.
- The Interest Expense is 61.74% of Operating Income.
- The Net Earning history of PBYI is 9.16% of Total Revenues.
- Per Share Earnings over the last 16 years have been positive in 9 years.
Puma Biotechnology Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | PBYI |
CUSIP: | 74587V |
Website: | pumabiotechnology.com |
Debt
Debt-to-Equity Ratio: | 1.86 |
---|---|
Current Ratio: | 1.57 |
Quick Ratio: | 1.45 |
Price-to-Earnings
Trailing P/E Ratio: | 10.8 |
---|---|
Forward P/E Ratio: | 9.26 |
PBYI Technical Analysis vs Fundamental Analysis
Sell
45
Puma Biotechnology (PBYI)
is a Sell
Is Puma Biotechnology a Buy or a Sell?
-
Puma Biotechnology stock is rated a Sell
The current Puma Biotechnology [PBYI] share price is $4.86. The Score for PBYI is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.